EXOME

all the information, none of the junk | biotech • healthcare • life sciences

Vaccsys Raises $9M in Series A

Vaccsys, a vaccine maker based in Seattle, has called down $9 million of an $18 million Series A round, according to Private Equity Hub, which cites a regulatory filing. The investors include Alta Partners, The Column Group, and Versant Ventures (all based in California).